MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

MDT

89.75

-0.24%↓

VEEV

281.77

+2.15%↑

A

120.9

-1.95%↓

WBA

11.48

-0.26%↓

HQY

96.76

+2.45%↑

Search

Cogent Biosciences Inc

Open

11.05 0.73

Overview

Share price change

24h

Current

Min

10.64

Max

11.17

Key metrics

By Trading Economics

Income

-4.1M

-72M

Employees

205

EBITDA

-1.2M

-74M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+69.76% upside

Dividends

By Dow Jones

Next Earnings

5 Aug 2025

Market Stats

By TradingEconomics

Market Cap

430M

1.1B

Previous open

10.32

Previous close

11.05

Technical Score

By Trading Central

Confidence

Bearish Evidence

Cogent Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

11 Jul 2025, 22:19 UTC

Acquisitions, Mergers, Takeovers

FCC Approves U.S. Cellular Sale to T-Mobile

11 Jul 2025, 17:28 UTC

Major Market Movers

SharpLink Gaming Gains on Ethereum Purchase

11 Jul 2025, 16:57 UTC

Earnings

BASF Cuts Outlook on Global Economy Uncertainty

13 Jul 2025, 23:54 UTC

Market Talk

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

13 Jul 2025, 23:49 UTC

Market Talk

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

13 Jul 2025, 23:49 UTC

Market Talk

Global Equities Roundup: Market Talk

13 Jul 2025, 23:40 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

13 Jul 2025, 23:40 UTC

Market Talk

Gold Advances Amid Rising Trade Tensions -- Market Talk

13 Jul 2025, 23:39 UTC

Market Talk

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

13 Jul 2025, 23:16 UTC

Earnings

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

13 Jul 2025, 23:16 UTC

Earnings

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

13 Jul 2025, 23:16 UTC

Earnings

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

13 Jul 2025, 23:13 UTC

Market Talk

Global Equities Roundup: Market Talk

13 Jul 2025, 23:13 UTC

Market Talk

Ryman Healthcare Could Be Turning a Corner -- Market Talk

13 Jul 2025, 11:00 UTC

Acquisitions, Mergers, Takeovers

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

12 Jul 2025, 02:24 UTC

Acquisitions, Mergers, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 Jul 2025, 02:05 UTC

Acquisitions, Mergers, Takeovers

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 Jul 2025, 02:05 UTC

Acquisitions, Mergers, Takeovers

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 Jul 2025, 02:05 UTC

Acquisitions, Mergers, Takeovers

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 Jul 2025, 21:45 UTC

Market Talk

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 Jul 2025, 19:46 UTC

Acquisitions, Mergers, Takeovers

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 Jul 2025, 19:45 UTC

Market Talk

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 Jul 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 Jul 2025, 18:18 UTC

Market Talk

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 Jul 2025, 17:35 UTC

Market Talk

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 Jul 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 Jul 2025, 16:53 UTC

Market Talk

Crude Futures Add to Early Gains -- Market Talk

11 Jul 2025, 16:42 UTC

Earnings

BASF Cuts Outlook on Global Economic Uncertainty

11 Jul 2025, 16:08 UTC

Market Talk

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 Jul 2025, 16:05 UTC

Earnings

BASF Will Publish Half-Year Results on July 30

Peer Comparison

Price change

Cogent Biosciences Inc Forecast

Price Target

By TipRanks

69.76% upside

12 Months Forecast

Average 18.64 USD  69.76%

High 28 USD

Low 9 USD

Based on 12 Wall Street analysts offering 12 month price targets forCogent Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

9

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

4.88 / 5.87Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Weak Bearish Evidence

Long Term

Strong Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.